Showing results (1-10 of 143) with videos related to
Sort By:
Pageof 15
Methods in Molecular Biology (Clifton, N.J.)|March 1, 2024
Targeted Modification of Epigenetic Marks Using CRISPR/dCas9-SunTag-Based Modular Epigenetic ToolkitMin Kyung Song, Yoon-Seong KimPlos One|July 28, 2022
NXP031 prevents dopaminergic neuronal loss and oxidative damage in the AAV-WT-α-synuclein mouse model of Parkinson's diseaseMin Kyung Song, Levi Adams, Joo Hee Lee, et al.Nature Aging|March 16, 2024
A single-nuclei paired multiomic analysis of the human midbrain reveals age- and Parkinson's disease-associated glial changesLevi Adams, Min Kyung Song, Samantha Yuen, et al.International Neurourology Journal|December 12, 2022
Regulation of Αlpha-Synuclein Gene (SNCA) by Epigenetic Modifier TET1 in Parkinson DiseaseSubhrangshu Guhathakurta, Min Kyung Song, Sambuddha Basu, et al.Neuroscience Letters|October 19, 2020
Neuroprotective effect of NXP031 in the MPTP-induced Parkinson's disease modelMin Kyung Song, Joo Hee Lee, Jinil Kim, et al.EMBO Molecular Medicine|January 11, 2021
Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson's diseaseSubhrangshu Guhathakurta, Jinil Kim, Levi Adams, et al.Neuroscience Letters|October 8, 2017
Mitochondrial ROS-mediated post-transcriptional regulation of α-synuclein through miR-7 and miR-153Goun Je, Yoon-Seong KimFree Radical Biology & Medicine|November 9, 2024
NXP031 restores memory function by dual effects degrading Aβ accumulation and facilitating antioxidant pathway in Alzheimer's disease modelsIn Gyoung Ju, Joo Hee Lee, Jae-Min Lee, et al.Experimental & Molecular Medicine|September 6, 2006
Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's diseaseYoon Seong Kim, Tong H JohBiomolecules & Therapeutics|October 12, 2013
Matrix metalloproteinases, new insights into the understanding of neurodegenerative disordersYoon-Seong Kim, Tong H JohPageof 15